-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Pieris Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2020 to Q2 2024.
- Pieris Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending June 30, 2024 was $0.000, a 100% decline year-over-year.
- Pieris Pharmaceuticals, Inc. Operating Lease, Payments for the twelve months ending June 30, 2024 was $1.2M, a 45.5% decline year-over-year.
- Pieris Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $2.2M, a 8.33% decline from 2022.
- Pieris Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $2.4M, a 7.69% decline from 2021.
- Pieris Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $2.6M, a 18.2% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)